BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 35921177)

  • 1. A Druggable Rheostat for Ewing Sarcoma?
    Weiss KR; Bailey KM
    Clin Cancer Res; 2022 Oct; 28(20):4360-4362. PubMed ID: 35921177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.
    Tanner JM; Bensard C; Wei P; Krah NM; Schell JC; Gardiner J; Schiffman J; Lessnick SL; Rutter J
    Mol Cancer Res; 2017 Nov; 15(11):1517-1530. PubMed ID: 28720588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.
    Niedan S; Kauer M; Aryee DN; Kofler R; Schwentner R; Meier A; Pötschger U; Kontny U; Kovar H
    Oncogene; 2014 Jul; 33(30):3927-38. PubMed ID: 23995784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
    Grohar PJ; Kim S; Rangel Rivera GO; Sen N; Haddock S; Harlow ML; Maloney NK; Zhu J; O'Neill M; Jones TL; Huppi K; Grandin M; Gehlhaus K; Klumpp-Thomas CA; Buehler E; Helman LJ; Martin SE; Caplen NJ
    Cell Rep; 2016 Jan; 14(3):598-610. PubMed ID: 26776507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.
    Gorthi A; Romero JC; Loranc E; Cao L; Lawrence LA; Goodale E; Iniguez AB; Bernard X; Masamsetti VP; Roston S; Lawlor ER; Toretsky JA; Stegmaier K; Lessnick SL; Chen Y; Bishop AJR
    Nature; 2018 Mar; 555(7696):387-391. PubMed ID: 29513652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.
    Lessnick SL; Ladanyi M
    Annu Rev Pathol; 2012; 7():145-59. PubMed ID: 21942527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor.
    Osgood CL; Maloney N; Kidd CG; Kitchen-Goosen S; Segars L; Gebregiorgis M; Woldemichael GM; He M; Sankar S; Lessnick SL; Kang M; Smith M; Turner L; Madaj ZB; Winn ME; Núñez LE; González-Sabín J; Helman LJ; Morís F; Grohar PJ
    Clin Cancer Res; 2016 Aug; 22(16):4105-18. PubMed ID: 26979396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
    Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells.
    Caropreso V; Darvishi E; Turbyville TJ; Ratnayake R; Grohar PJ; McMahon JB; Woldemichael GM
    J Biol Chem; 2016 May; 291(19):10058-66. PubMed ID: 26961871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma.
    Sankar S; Tanner JM; Bell R; Chaturvedi A; Randall RL; Beckerle MC; Lessnick SL
    Mol Cell Biol; 2013 Nov; 33(22):4448-60. PubMed ID: 24043308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma.
    Shi X; Zheng Y; Jiang L; Zhou B; Yang W; Li L; Ding L; Huang M; Gery S; Lin DC; Koeffler HP
    Nucleic Acids Res; 2020 Nov; 48(20):11434-11451. PubMed ID: 33080033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-FLI1 employs an E2F switch to drive target gene expression.
    Schwentner R; Papamarkou T; Kauer MO; Stathopoulos V; Yang F; Bilke S; Meltzer PS; Girolami M; Kovar H
    Nucleic Acids Res; 2015 Mar; 43(5):2780-9. PubMed ID: 25712098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.
    Lu DY; Ellegast JM; Ross KN; Malone CF; Lin S; Mabe NW; Dharia NV; Meyer A; Conway A; Su AH; Selich-Anderson J; Taslim C; Byrum AK; Seong BKA; Adane B; Gray NS; Rivera MN; Lessnick SL; Stegmaier K
    Nat Cell Biol; 2023 Feb; 25(2):285-297. PubMed ID: 36658220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcoma.
    Shirai R; Biebighauser T; Walker D; Oviedo J; Nelson-Taylor S; Bodlak A; Porfilio T; Oike N; Goodspeed A; Hayashi M
    PLoS One; 2024; 19(6):e0305490. PubMed ID: 38875295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells.
    Khoogar R; Li F; Chen Y; Ignatius M; Lawlor ER; Kitagawa K; Huang TH; Phelps DA; Houghton PJ
    Cell Oncol (Dordr); 2022 Feb; 45(1):19-40. PubMed ID: 34997546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles.
    Ruzanov P; Evdokimova V; Pachva MC; Minkovich A; Zhang Z; Langman S; Gassmann H; Thiel U; Orlic-Milacic M; Zaidi SH; Peltekova V; Heisler LE; Sharma M; Cox ME; McKee TD; Zaidi M; Lapouble E; McPherson JD; Delattre O; Radvanyi L; Burdach SE; Stein LD; Sorensen PH
    J Clin Invest; 2024 Mar; 134(9):. PubMed ID: 38530366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor Microenvironment.
    Wrenn ED; Apfelbaum AA; Rudzinski ER; Deng X; Jiang W; Sud S; Van Noord RA; Newman EA; Garcia NM; Miyaki A; Hoglund VJ; Bhise SS; Kanaan SB; Waltner OG; Furlan SN; Lawlor ER
    Clin Cancer Res; 2023 Dec; 29(24):5140-5154. PubMed ID: 37471463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Intracranial Ewing Sarcoma Invading the Superior Sagittal Sinus with EWSR1-FLI1 Gene Fusion and EWSR1 Gene Mutation: A Case Report and Literature Review.
    Geng Z; Gao W; Cheng W; Wu A
    World Neurosurg; 2023 Jul; 175():1-10. PubMed ID: 36990350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic identification of genomic markers of drug sensitivity in cancer cells.
    Garnett MJ; Edelman EJ; Heidorn SJ; Greenman CD; Dastur A; Lau KW; Greninger P; Thompson IR; Luo X; Soares J; Liu Q; Iorio F; Surdez D; Chen L; Milano RJ; Bignell GR; Tam AT; Davies H; Stevenson JA; Barthorpe S; Lutz SR; Kogera F; Lawrence K; McLaren-Douglas A; Mitropoulos X; Mironenko T; Thi H; Richardson L; Zhou W; Jewitt F; Zhang T; O'Brien P; Boisvert JL; Price S; Hur W; Yang W; Deng X; Butler A; Choi HG; Chang JW; Baselga J; Stamenkovic I; Engelman JA; Sharma SV; Delattre O; Saez-Rodriguez J; Gray NS; Settleman J; Futreal PA; Haber DA; Stratton MR; Ramaswamy S; McDermott U; Benes CH
    Nature; 2012 Mar; 483(7391):570-5. PubMed ID: 22460902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ewing Sarcoma Related protein 1 recognizes R-loops by binding DNA forks.
    Lay MA; Thompson VF; Adelakun AD; Schwartz JC
    Biopolymers; 2024 May; 115(3):e23576. PubMed ID: 38511874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.